A detailed history of Toroso Investments, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Toroso Investments, LLC holds 4,812 shares of ITCI stock, worth $403,630. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,812
Previous 4,812 -0.0%
Holding current value
$403,630
Previous $351,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$67.99 - $80.84 $4,827 - $5,739
71 Added 1.5%
4,812 $351,000
Q2 2024

Aug 14, 2024

BUY
$64.76 - $79.84 $67,544 - $83,273
1,043 Added 28.2%
4,741 $324,000
Q1 2024

May 15, 2024

BUY
$64.37 - $75.65 $28,966 - $34,042
450 Added 13.85%
3,698 $255,000
Q4 2023

Feb 14, 2024

BUY
$46.37 - $73.65 $150,609 - $239,215
3,248 New
3,248 $232,000
Q1 2023

May 15, 2023

BUY
$43.8 - $56.99 $174,324 - $226,820
3,980 New
3,980 $216,000

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.92B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Toroso Investments, LLC Portfolio

Follow Toroso Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toroso Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Toroso Investments, LLC with notifications on news.